Women | Men | |||||||
---|---|---|---|---|---|---|---|---|
95% CIs | P-value | Statistic | 95% CIs | P-value | ||||
General CVD riskb | ||||||||
Absolute IDI (%) | -0.005 | -0.009 | -0.002 | 0.004 | -0.003 | -0.006 | -0.001 | 0.006 |
Relative IDI (%) | -0.039 | -0.064 | -0.014 | 0.002 | -0.025 | -0.042 | -0.007 | 0.005 |
Cut-point-based NRI c (%) | -0.018 | -0.053 | 0.017 | 0.310 | -0.004 | -0.028 | 0.021 | 0.764 |
Cut-point-free NRI (%) | -0.221 | -0.354 | -0.089 | 0.001 | -0.173 | -0.258 | -0.089 | 0.000 |
WHtR | ||||||||
Absolute IDI (%) | -0.044 | -0.054 | -0.035 | 0.000 | -0.017 | -0.022 | -0.012 | 0.000 |
Relative IDI (%) | -0.262 | -0.298 | -0.225 | 0.000 | -0.115 | -0.147 | -0.084 | 0.000 |
Cut-point-based NRI c (%) | -0.077 | -0.141 | -0.013 | 0.019 | -0.008 | -0.042 | 0.025 | 0.632 |
Cut-point-free NRI (%) | -0.052 | -0.140 | 0.036 | 0.250 | 0.010 | -0.070 | 0.091 | 0.800 |
WHpR | ||||||||
Absolute IDI (%) | -0.028 | -0.037 | -0.020 | 0.000 | -0.012 | -0.017 | -0.008 | 0.000 |
Relative IDI (%) | -0.185 | -0.228 | -0.142 | 0.000 | -0.085 | -0.113 | -0.057 | 0.000 |
Cut-point-based NRI c (%) | -0.027 | -0.084 | 0.030 | 0.345 | 0.003 | -0.030 | 0.035 | 0.878 |
Cut-point-free NRI (%) | -0.177 | -0.294 | -0.060 | 0.003 | -0.122 | -0.207 | -0.037 | 0.005 |
BMI | ||||||||
Absolute IDI (%) | -0.038 | -0.047 | -0.029 | 0.000 | 0.055 | 0.042 | 0.068 | 0.000 |
Relative IDI (%) | -0.233 | -0.270 | -0.197 | 0.000 | 0.727 | 0.481 | 0.973 | 0.000 |
Cut-point-based NRI c (%) | -0.067 | -0.125 | -0.010 | 0.022 | 0.346 | 0.286 | 0.406 | 0.000 |
Cut-point-free NRI (%) | -0.031 | -0.120 | 0.059 | 0.501 | 0.507 | 0.423 | 0.592 | 0.000 |